A Current state of urological cryosurgery: prostate and kidney

(de la Revista "BJU International" Vol. 105 (5) 01/03/2010)

Prostate cancer continues to be the most prevalent cancer in American men and while the lifetime risk of mortality from the disease is approximate to 4%, we remain unable to identify which individuals actually harbour this risk. PSA measurements

alone lack the sensitivity and specificity to identify men at risk for the disease, as well as in predicting organ-confined disease, yet it remains the best tool we have to date.Thus, we remain with the dilemma of who to biopsy, and if the biopsy is positive who to treat. To date, no study has shown oncological superiority for any type of curative therapy for localized prostate cancer and various options exist [1], which leads us to the initial focus of this article. What is the current state of cryosurgery for localized prostate cancer? The second focus regards the use of cryosurgery for management of localized RCC.

NOTA: se presentan los resúmenes (abstracts) de los artículos como fueron publicados libremente en los respectivos sitios de las publicaciones. Es probable que el sitio EXTERNO a la SMU, en  donde se encuentra alojado el artículo completo, le pida una suscripción o cuota. La SMU y/o el editor de la página y/o Medisoft, no proporcionan claves, créditos o acceso a dichos artículos. Es responsabilidad de los visitantes solicitar y adquirir los artículos de su interés a cada uno de las publicaciones propietarios de dichos artículos.